BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32241875)

  • 1. Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis.
    Rinninella E; Fagotti A; Cintoni M; Raoul P; Scaletta G; Scambia G; Gasbarrini A; Mele MC
    Int J Gynecol Cancer; 2020 May; 30(5):654-663. PubMed ID: 32241875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.
    Rinninella E; Cintoni M; Raoul P; Pozzo C; Strippoli A; Bria E; Tortora G; Gasbarrini A; Mele MC
    Clin Nutr; 2020 Jul; 39(7):2045-2054. PubMed ID: 31718876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
    Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
    Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis.
    Jin Y; Ma X; Yang Z; Zhang N
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):697-705. PubMed ID: 36720459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.
    Ubachs J; Ziemons J; Minis-Rutten IJG; Kruitwagen RFPM; Kleijnen J; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1165-1174. PubMed ID: 31389674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis.
    Rinninella E; Cintoni M; Raoul P; Ponziani FR; Pompili M; Pozzo C; Strippoli A; Bria E; Tortora G; Gasbarrini A; Mele MC
    Intern Emerg Med; 2021 Aug; 16(5):1341-1356. PubMed ID: 33337518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant).
    Ning L; Hu YC; Wang S; Lang JH
    Medicine (Baltimore); 2018 Aug; 97(32):e11481. PubMed ID: 30095613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of sarcopenia in patients with rectal cancer: A meta-analysis.
    Zhu Y; Guo X; Zhang Q; Yang Y
    PLoS One; 2022; 17(6):e0270332. PubMed ID: 35749415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of systematic lymphadenectomy during debulking surgery in the treatment of ovarian cancer: a meta-analysis of randomized controlled trials.
    Lin Q; Liu W; Xu S; Li J; Tong J
    J Ovarian Res; 2020 May; 13(1):56. PubMed ID: 32384898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
    Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
    Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials.
    Rinninella E; Fagotti A; Cintoni M; Raoul P; Scaletta G; Quagliozzi L; Miggiano GAD; Scambia G; Gasbarrini A; Mele MC
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31234395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
    Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
    Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
    Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
    JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Low Skeletal Muscle Mass on Post-operative Survival of Patients With Abdominal Aortic Aneurysm: A Prognostic Factor Review and Meta-Analysis of Time-to-Event Data.
    Antoniou GA; Rojoa D; Antoniou SA; Alfahad A; Torella F; Juszczak MT
    Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):190-198. PubMed ID: 31204184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis.
    Xie H; Wei L; Liu M; Yuan G; Tang S; Gan J
    Langenbecks Arch Surg; 2021 Sep; 406(6):1775-1788. PubMed ID: 34406490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang Z; Gu JH; Guo CS; Li XH; Yang WC
    Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sarcopenia and low muscle attenuation on outcomes of ovarian cancer: a systematic review and meta-analysis.
    Ge HP; Song DF; Wu P; Xu HF
    Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4544-4562. PubMed ID: 37259736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.